Document |
Document Title |
WO/2016/159650A1 |
The present invention relates to a poly(sodium phosphate) supported catalyst having improved activity and to a method wherein methyl ethyl ketone and 1,3-butadiene are produced from 2,3-butanediol by using same, and more specifically rel...
|
WO/2016/153906A1 |
Disclosed herein are embodiments of multicyclic compounds and methods of making such compounds. The disclosed methods reduce step-counts in the synthesis of complex targets, while reducing costs and waste streams.
|
WO/2016/153432A1 |
The present invention relates to substituted phenyl cinnamyl ketones of Formula (I) for use in therapy: wherein R1 to R11 are defined as described in the specification, or a pharmaceutically acceptable salt, tautomer(s), solvate or polym...
|
WO/2016/151990A1 |
The present invention relates to novel tertiary alcohol derivatives substituted with aryl and trifluoromethyl, and optical isomers thereof. In addition, the present invention also relates to methods for the preparation and use as enantio...
|
WO/2016/146299A1 |
A process to isolate a compound of Formula (2a) or a salt or solvate thereof, comprising a) reacting a mixture of diastereoisomers of Formulae (2a, 2b) with a basic heterocyclic-aldehyde compound and an optically active amine in the pres...
|
WO/2016/146588A1 |
The present invention relates to compounds of formula (I): in which R1 is a hydrogen atom, a phenyl radical, or a straight or branched, saturated or unsaturated hydrocarbon radical having 1 to 8 carbon atoms.
|
WO/2016/143561A1 |
The present invention provides a new organic ligand capable of providing a complex that has a three-dimensional network structure due to rare-earth element ions. Also provided is a new polymer complex which includes this organic ligand, ...
|
WO/2016/143634A1 |
Provided is a bimesogenic compound which exhibits high solubility in other bimesogenic compounds and substances used in conventional liquid crystal display elements, such as liquid crystalline compounds, liquid crystal compositions, chir...
|
WO/2016/143562A1 |
The rare earth complex according to the present invention has a rare earth atom, an organic ligand coordinated to the rare earth atom, and a polyoxometalate that contains a metal atom and an oxygen atom and that is coordinated to the rar...
|
WO/2016/139373A1 |
Molecular storage materials for incorporating small molecules in solid matrices may find applications in structure elucidation, decontamination, and slow release of active ingredients. The syntheses of 1,3,5,7-tetrakis(2,4-dimethoxypheny...
|
WO/2016/133940A1 |
Provided herein are compositions and processes of making of anticancer compounds useful for cancer treatments. These cyclohexenone compounds show an unexpected result against certain cancer cells compared to their known analogs.
|
WO/2016/126624A1 |
Disclosed are methods for the catalytic transestenfication of compounds having one or more ester groups and groups reactive under transestenfication conditions, such as 1, 1-disubstituted alkene compounds, with alcohols or esters and nov...
|
WO/2016/123044A1 |
This document provides methods and materials for treating endometriosis. For example, methods and materials for using histone acetyl transferase inhibitors (e.g., garcinol) to treat endometriosis are provided.
|
WO/2016/120574A1 |
The present invention relates to: - an adduct between a Lewis acid, preferably aluminum trichloride, iron trichloride, or zinc dichloride, and a hydrosilane; - a method for preparing same; and - use of same in a reaction for reducing, pa...
|
WO/2016/117663A1 |
The invention provides a precipitation accelerator that is an organic compound having one or more straight-chain aliphatic hydrocarbon groups having 10 or more carbon atoms, the total number of carbon atoms in these aliphatic hydrocarbon...
|
WO/2016/116776A1 |
A gold/titanium nanotube-multiwalled carbon nanotube composite (Au/TNT-MWCNT) is presented. The gold composition comprises at least 3 % weight of the nanotube composite based on the total weight of the nanotube composite and the gold com...
|
WO/2016/114687A1 |
The invention relates to a method of producing carbonyl compounds, more particularly С2-С4 ketones and aldehydes. The method is based on the gas-phase oxidation by nitrous oxide of С2-С4 alkane-olefin mixtures, such as a butane-butyl...
|
WO/2016/114668A1 |
The present invention is directed to a method for preparing a final phenolic product from biomass comprising the steps of providing a furanic compound obtainable from biomass; reacting the furanic compound with a dienophile to obtain a p...
|
WO/2016/111256A1 |
The present invention pertains to a raw material comprising an organic iridium material for producing a cyclometallized iridium complex, wherein the organic iridium material is tris(β-diketonate)iridium (III) represented by general form...
|
WO/2016/109470A1 |
Small molecule stimulators of steroid receptor coactivator (SRC) family proteins are provided, as well as methods for their use in treating or preventing cancer. Also provided are methods for stimulating SRC family proteins in a cell.
|
WO/2016/107582A1 |
The invention relates to bioactive compounds purified from mycelium of Antrodia camphorata and the manufacturing method thereof. A method for treatment of cancers by administrating an effective amount of the said compounds selected from ...
|
WO/2016/102472A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (1): in which: - R1 means a hydrogen atom, a linear or branched C1-C6 alkyl radical; ...
|
WO/2016/104474A1 |
Provided is a method for producing a compound represented by general formula (I) by oxidative cleavage of a compound of formula (II), which is a bicyclic 4-substituted olefin compound, using hydrogen peroxide. The method for producing a ...
|
WO/2016/102475A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (I) in which: - R3 means a hydrogen atom or a hydroxyl radical, - R1 and R2 mean, ind...
|
WO/2016/097238A1 |
The present invention relates to -(7,10,10-trimethyl-4-bicyclo[6.2.0]decanyl)ethanone, the use of 1-(7,10,10-trimethyl-4-bicyclo[6.2.0]decanyl)ethanone as a fragrance or as flavor, to a method for imparting or modifying a scent or a flav...
|
WO/2016/096539A1 |
The invention relates to special phenacyl ethers of formula (I), as defined herein, which can be used as photolabile pro-fragrances. The invention further relates to detergents and cleaning agents, cosmetic agents and air freshening prod...
|
WO/2016/095870A1 |
Provided are a bisphenol and diamine containing benzocyclobutene structural unit, and preparation and application thereof; specifically, the present invention uses 4-halo-benzocyclobutene as a raw material to obtain 4-acyl-benzocyclobute...
|
WO/2016/098899A1 |
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] A ketone or oxime compound represented by formula (1) and a herbicide containing the same (in the formula: B represents B-1, B-2, or B-3; Q rep...
|
WO/2016/097239A1 |
The present invention relates to a process for preparing 1-[(1R,4R/S,8S)-10,10-dimethyl-7-methylene-4-bicyclo[6.2.0]d
ecanyl]ethanone.
|
WO/2016/097612A1 |
The present invention relates to a process for preparing a product of formula I: characterized in that the reaction is catalyzed both by thiamine or a thiamine salt and by ascorbic acid in a form which is free or salified or an organic a...
|
WO/2016/091058A1 |
Disclosed is a method for preparing 3-pentanone from 2-pentene. The method comprises the following steps: 1) 2-pentene and acetic acid are mixed and an addition reaction takes place in a liquid phase through a catalyst bed, and special c...
|
WO/2016/090707A1 |
The present invention relates to synthesis of m-hydroxyacetophenone by means of a one-pot method, which comprises the following steps: S1, water is added to a reaction kettle, reduced iron powders are added under stirring, then a concent...
|
WO/2016/089893A1 |
The present invention relates to pharmaceutical compositions of an non-steroidal anti- inflammatory drug (NSAIDs) such as, aspirin, diclofenac, ibuprofen, ketoprofen, or naproxen, or any pharmaceutically acceptable salts, solvates, or pr...
|
WO/2016/087807A1 |
The invention relates to a process for the synthesis of a compound having the following formula (I), or a salt thereof, in which formula (I) R is a COOH, CH2OH or CHO group, comprising the step according to which but-3-ene-1,2-diol (BDO)...
|
WO/2016/083256A1 |
Process for the manufacture of at least one alcohol and/or at least one ketone, which comprises a step during which at least one organic peroxide compound is put into contact with at least one catalyst responding to formula (I) CrNxOy Fo...
|
WO/2016/085981A1 |
A therapeutic use of trans-geranylgeranylacetone and its analogs is described, along with methods of inhibiting, reducing, or treating fibrosis, by administering the trans isomer of geranylgeranylacetone or an analog thereof.
|
WO/2016/079103A1 |
The present invention relates to a process for the preparation of 1-(2,6,6- trimethylcyclohexyl)-alkan-3-ols, in particular 1-(2,6,6-trimethylcyclohexyl)-hexan-3-ol. The invention further relates to 5-alkoxy-1-(2,6,6-trimethylcyclohexeny...
|
WO/2016/078505A1 |
Provided is a preparation method of a fluorene ethyl ketone derivative, particularly a preparation method of a compound of formula I, each group being as defined in the specification. The compound can be used as an intermediate in the pr...
|
WO/2016/078673A1 |
The present invention concerns a process for converting biomass into useful organic building blocks for the chemical industry. The process involves the reduction of a polyol wherein at least two of the hydroxyl groups are located on adja...
|
WO/2016/075047A1 |
An industrial scale continuous process for the production and recovery of cyclohexanone from phenol and hydrogen, said process comprising: hydrogenating phenol in a phenol hydrogenation reactor; separating cyclohexanone from a hydrogenat...
|
WO/2016/071425A1 |
The invention discloses a method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous Pd catalyzed fluoro, chloro and fluorochloro alkylation with fluoro, chloro and fluorochloroalkyl halides in the prese...
|
WO/2016/071243A1 |
The present invention relates to a process for preparing a compound of formula (III) starting from the vinyl ether (IlIa) and the compound (IIIb) with a reagent (lllc) selected from the group of sulfonylhalides or sulfonylanhydrides, e.g...
|
WO/2016/066116A1 |
Provided are a preparation method of Apremilast and intermediates thereof. Also provided is an Apremilast intermediate shown by Formula III, wherein Apremilast is obtained with the compound of Formula III sequentially reacting with methy...
|
WO/2016/067844A1 |
In order to rapidly and highly selectively decompose a hydroperoxide of a hydrocarbon compound, and to produce a target ketone and/or alcohol, this method for producing a ketone and/or alcohol involves decomposing a hydroperoxide in a re...
|
WO/2016/064245A1 |
A novel peptide compound, a production method therefor, and a use thereof are provided. The compound has an anticancer activity, and thus the compound can be used for preventing or treating cancer.
|
WO/2016/063296A1 |
The present invention relates to the polyprenylated phloroglucinol compounds of formulae I and II. The present invention also provides synthesis and p-glycoprotein induction activity of the alkyl- and acyl- polyprenylated phloroglucinol ...
|
WO/2016/062867A1 |
The present invention relates to a method for producing a gypsum-containing foamed prefabricated building material and to a gypsum-containing foamed prefabricated building material.
|
WO/2016/058896A1 |
The invention relates to a a process for the preparation of a compound of formula I comprising a) reacting a compound of formula II in the presence of magnesium or an organometallic reagent of formula III R1M2X (III), wherein R1 is CI-C4...
|
WO/2016/059972A1 |
The purpose of the present invention is to provide a photovoltaic element having high photoelectric conversion efficiency as well as excellent processing properties/low environmental load. Specifically, the present invention is: an organ...
|
WO/2016/058882A1 |
The invention relates to a process for the preparation of a compound of formula I (I), wherein R1 is hydrogen, fluoro or chloro; which process comprises a) reacting a compound of formula II (II), wherein R1 is hydrogen, fluoro or chloro;...
|